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Abstract
In recent years, the use of fluorescence-guided surgery 
(FGS) to treat benign and malignant visceral, hepatobiliary 
and pancreatic neoplasms has significantly increased. 
FGS relies on the fluorescence signal emitted by injected 
substances (fluorophores) after being illuminated by ad 
hoc laser sources to help guide the surgical procedure 
and provide the surgeon with real-time visualization of the 
fluorescent structures of interest that would be otherwise 
invisible. This review surveys and discusses the most 
common and emerging clinical applications of indocyanine 
green (ICG)-based fluorescence in visceral, hepatobiliary 
and pancreatic surgery. The analysis, findings, and 
discussion presented here rely on the authors’ signi-
ficant experience with this technique in their medical 
institutions, an up-to-date review of the most relevant 
articles published on this topic between 2014 and 2018, 
and lengthy discussions with key opinion leaders in the 
field during recent conferences and congresses. For each 
application, the benefits and limitations of this technique, 
as well as applicable future directions, are described. The 
imaging of fluorescence emitted by ICG is a simple, fast, 
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relatively inexpensive, and harmless tool with numerous 
different applications in surgery for both neoplasms and 
benign pathologies of the visceral and hepatobiliary 
systems. The ever-increasing availability of visual systems 
that can utilize this tool will transform some of these 
applications into the standard of care in the near future. 
Further studies are needed to evaluate the strengths and 
weaknesses of each application of ICG-based fluorescence 
imaging in abdominal surgery. 
Key words: Indocyanine green; Fluorescence imaging; 
Gastrointestinal surgery; Liver surgery; Biliary surgery; 
Pancreatic surgery; visceral perfusion; Biliary anatomy; 
Peritoneal carcinomatosis
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Core tip: In recent years, the use of fluorescence-
guided surgery to treat benign and malignant visceral, 
hepatobiliary and pancreatic neoplasms has significantly 
increased. It helps guide the surgical procedure and 
provides the surgeon with real-time visualization of 
the fluorescent structures of interest that would be 
otherwise invisible. This review surveys and discusses 
the most common and emerging clinical applications 
of indocyanine green-based fluorescence in visceral, 
hepatobiliary and pancreatic surgery. The ever-
increasing availability of visual systems that can utilize 
this tool will transform some of these applications into 
the standard of care in the near future.
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INTRODUCTION
Fluorescence-guided surgery (FGS) is a modality of 
intraoperative navigation that provides the surgeon 
with enhanced visualization of anatomical structures 
and/or an improved understanding of an organ’s 
current perfusion in real time[1,2]. To obtain a fluore-
scence signal, the operative field is exposed to near-
infrared light sources, while the target is injected with 
a fluorescent dye, which can emit a fluorescence 
signal after being excited by ad hoc laser sources. The 
fluorescence signal can be visualized either directly on 
the operative field during open surgical procedures or 
captured by specific cameras and displayed on a screen 
in a minimally invasive setting. FGS is currently more 
adapted to the needs of surgical navigation because it 
does not require bulky equipment in the operating room 
and the enhanced information provided to the surgeon 
is displayed in real time, without interfering with the 
surgical workflow[3].
In the last few years, fluorescence imaging using 
the fluorescent properties of indocyanine green (ICG) 
has become widespread in several medical and surgical 
specialties[4]. Due to its relatively low cost and high 
availability, ICG is the most employed fluorophore in the 
clinical setting of general surgery.
The main goal of this overview is to survey and 
discuss the most recent and ongoing clinical applications 
of ICG-based fluorescence in visceral, hepatobiliary 
and pancreatic (HBP) surgery. Up to date, vascular 
assessment of anastomotic stump in visceral surgery 
and extrahepatic biliary anatomy identification during 
difficult cholecystectomies are the most well established 
applications of ICG-based fluorescence surgery.
The in-depth analysis presented here relies on 
three main sources of information. First, the analysis 
draws on the authors’ significant experience with this 
technology in their medical institutions. Second, an up-
to-date review of the most relevant articles published 
on this topic between 2014 and 2018 presents the 
latest developments in this rapidly developing field. 
Lastly, lengthy discussions of the authors with key 
opinion leaders in the field during recent conferences 
and congresses add novel insights on the ongoing 
applications that will appear in the literature in the 
near future. In particular, the rationale of applying this 
technique to visceral and HBP surgery, the relevant 
physiopathological insights, the available data, and 
the ongoing clinical trials are thoroughly surveyed 
and discussed. For each application, the benefits 
and limitations of this technique are identified, and 
applicable future directions are described.
Real-TIme VIsCeRal PeRfUsION
The estimation of real-time visceral perfusion is a 
promising intraoperative application of ICG-based 
fluorescence surgery. ICG-based fluorescence angio-
graphy might guide the identification of the optimal 
resection site and help estimate the blood supply of 
visceral anastomosis in both upper GI and colorectal 
surgery. The rationale behind fluorescence angiography 
is that the fluorescent dye, upon systemic injection, 
should reach and highlight only vascularized areas. 
Focusing on colorectal surgery, it is well known that 
the rate of anastomotic leaks ranges between 5% and 
7%, even in high-volume centers[5]. The introduction 
into daily clinical practice of a tool capable of delivering 
optimal stump vascularization could reduce this rate. In 
turn, this may eliminate dehiscence due to inadequate 
vascularization despite a macroscopically satisfactory 
appearance[6-8]. Some phase II trials have confirmed 
the feasibility, low cost, and high success rate of this 
procedure[9], reporting a leakage rate (< 3%) lower 
than the one expected on the basis of historical series 
in rectal anastomoses. The rate of changes in the 
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transection line varies from 5% to 40%[10]. However, 
a few reports did not confirm these data; for instance, 
in a series of 346 colorectal interventions, Kin and 
colleagues reported a leakage rate of 7.5% and 6.4% 
with and without ICG intraoperative assessment, 
respectively[11]. Some randomized prospective controlled 
trials are currently ongoing[12]. 
Similar use of ICG for intraoperative assessments 
has been investigated for esophagectomy and 
gastrectomy. When making the gastric tube during 
esophagectomy, the most cranial portion represents a 
critical point because the gastroepiploic vascularization 
reaches a macroscopically unclear cut-off at that 
level[13]. A few retrospective, case-control studies 
have confirmed this hypothesis, showing a number of 
changes in the site of anastomosis as high as 25% and 
a reduction in the leakage rate from 18% to 3% and 
from 15% to 6% in the series reported by Karampinis 
and Kitagawa, respectively[14,15]. In a consecutive series 
of 40 patients undergoing the Ivor-Lewis procedure, 
Koyanagi et al[16] compared the blood flow using ICG 
in the gastric conduit and in the greater curve; by 
employing ROC analysis, they identified a speed of 1.76 
cm/s as the cut-off value predicting leakage. However, 
even in esophageal surgery, the lack of prospective 
randomized trials hampers the possibility of reaching 
a definitive conclusion supporting evaluation of the 
perfusion of the gastric conduit using ICG-based 
fluorescence. 
The same principles for checking the perfusion of the 
upper extremity of the stomach transection line apply to 
sleeve gastrectomy in bariatric surgery. Identifying the 
less vascularized proximal area would allow a targeted 
resection and reduce the leakage rate along the suture 
line[17]. 
In many other clinical settings, the estimation of 
visceral perfusion may turn out to be a useful and 
relatively inexpensive intraoperative tool, for example, 
to assess the small bowel trophism during urgent 
interventions for intestinal ischemia, after mistaken 
mesocolon interruption, and/or small bowel mesenteric 
division[18].
Identification of the major vascular structures in 
the early phase of dissection from the surrounding 
fat might be an additional and potentially very useful 
development from a theoretical point of view. Small 
intravenous boluses of ICG can facilitate navigation of 
the vascular structure. However, the penetration depth 
of the fluorescence is limited to 5-6 mm; furthermore, 
after the injection, the tissues surrounding both the 
large arteries and veins become fluorescent, causing a 
background fluorescence field that reduces visualization. 
Finally, from then on, the bowel exhibits background 
staining, which could reduce the clarity of stump 
perfusion as evaluated at the time of anastomosis. For 
these reasons, repeated intraoperative angiographies 
for visualizing the main vascular structure are not 
possible with ICG. 
BIlIaRy aNaTOmy
ICG-based fluorescence imaging to visualize and study 
biliary anatomy represents one of the most established 
applications of this technique in abdominal surgery. The 
reason is simple: the exclusively hepatic metabolism 
of ICG, which results in biliary excretion starting 
approximately 30 min after i.v. injection, enables clear 
visualization of the biliary anatomy, which is very 
useful during difficult cholecystectomies[19] and from a 
theoretical point of view during the resection of centrally 
located liver tumors and hilar (Klatskin’s) tumors[20]. 
There is more than one comparative study that, 
although always retrospective, enables us to conclude 
that ICG-based fluorescence imaging is an extremely 
useful tool when applied to visualize and study the 
biliary anatomy[21]. In a systematic review published in 
2017, 19 studies were analyzed. There was moderate-
quality evidence that ICG-assisted visualization of 
the extrahepatic bile duct is superior to intraoperative 
cholangiogram (RR = 1.16; 95%CI: 1.00-1.35)[22]. 
While the difference was not significant in that study, 
it was significant in some other single-center series[23]. 
Considering the relative ease and speed of the procedure, 
in the future, ICG-based visualization of the biliary 
anatomy might replace intraoperative cholangiography, 
which requires a preliminary dissection of the confluence 
between the cystic and bile ducts and cannulation of the 
structures.
Recently, in an experimental study with a limited 
number of cases (7 pigs), ICG injection directly into 
the gallbladder enabled superior biliary anatomy 
visualization compared to i.v. injection[24]. The same 
study group translated their analysis to patients in a 
subsequent series of 46 cases[25].
With the aim of overcoming the limits of retro-
spective data, a prospective randomized controlled trial 
(FALCON) was set up in 2016 to compare near-infrared 
fluorescence cholangiography-assisted laparoscopic 
cholecystectomy versus conventional laparoscopic 
cholecystectomy. The results are expected in 2 years[26].
The main point of debate remains the ideal 
injection time. Although fluorescence of the bile duct 
can be detected shortly after i.v. injection, the high 
fluorescence of the liver parenchyma makes it less 
evident in contrast. In our view, the ideal timing for this 
injection is 3 to 5 h before surgery. However, a recent 
series demonstrated that an injection 24 h before 
surgery could still be possible[27]. 
lIVeR sURgeRy
In liver surgery, the state of the art still considers 
ICG mainly as a simple reagent for the preoperative 
evaluation of hepatic function. The comparatively 
limited use of ICG-based fluorescence imaging in liver 
surgery with respect to other surgical specialties is 
slightly paradoxical, considering the pathophysiological 
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and time consuming[37]. The presence of the nontumor 
tissue ring can also be a useful indicator of the extent of 
resection required to obtain an adequate free margin[38].
Second, there is an increasing need to treat patients 
with liver metastases after they have undergone 
multiple chemotherapy cycles; in these cases, nontumor 
parenchyma is hardened and metastases are largely 
necrotic, and, hence, softer. For this reason, the normal, 
easy tactile perception of metastasis is more difficult, 
and finding a fluorescent area can be of great help.
The third application pertains to some primary liver 
neoplasms without a capsule, for which it is difficult to 
assess the optimum extent of the resection. In these 
cases, a good rule should be to check the absence of 
complete residual fluorescence at the end of the surgical 
transection. 
Fourth, there are neoplasms with peripheral biliary 
infiltration and peribiliary spreading, which are not 
clearly recognizable by preoperative study, except 
for data indicating a dilatation of the upstream biliary 
structures[39]. In these cases, ICG retention affects the 
whole area that drains the Glisson segment and not just 
the nodule, suggesting the need for a wider resection. 
Moreover, some authors have assessed the use of 
ICG for detecting biliary leaks in the hepatic transection 
surface after liver resection[40]. Finally, experimental 
studies involving intraportal and intrahepatic artery ICG 
injection (by celiac trunk catheterization in experimental 
models and by femoral puncture in hybrid operating 
rooms) have been published with the aim of achieving 
precise, real-time definitions of liver segmentation[41-43].
The lesion depth represents the major limitation 
in applying ICG-based fluorescence imaging to liver 
surgery. Further technological improvements are 
needed to deepen the fluorescence penetration more 
than the current 5-6 millimeters[44,45]. In addition, few 
data exist regarding extrahepatic HCC metastases, but 
this may represent a promising clinical application for 
FGS[46].
ONCOlOgICal sURgeRy Of The UPPeR 
aND lOweR gI TRaCTs
The simplest use of ICG to surgically treat cancers 
affecting the digestive tract consists of endoscopically 
marking tumors to see the tumor site, which is 
necessary for small and nonserous infiltrating cancers. 
In this context, ICG is similar to other dyes used to date 
(China, indigo carmine)[47,48].
However, the most intriguing and potentially 
powerful application of FGS is currently one involving 
nodal navigation in esophageal, gastric, and colorectal 
cancers[49]. Injection of the dye into peritumoral tissues, 
ideally performed endoscopically in the submucosa, 
should allow for the intraoperative evaluation of 
lymphatic diffusion in real time. Multicentric prospective 
series are already available on the use of ICG to 
identify the sentinel lymph node in gastric cancer. 
assumption that ICG exhibits only hepatic metabolism 
and only bile excretion. In addition, many centers 
devoted to liver surgery use the ICG clearance rate as a 
reliable liver function indicator[28,29].
During the development of fluorescence cholan-
giography, it was discovered that ICG accumulates 
in the cancerous tissues of hepatocellular carcinoma 
(HCC) and in the noncancerous hepatic parenchyma 
around adenocarcinoma foci. The first application 
of this imaging technique was reported in 2009 by 
Ishizawa et al[30] and Gotoh et al[31]. 
From a theoretical point of view, three remarks 
should be taken into consideration. First, in HCC (which 
obviously contains hepatocytes), ICG can be captured 
and retained by malignant cells; moreover, the secretion 
of ICG may be altered due to architectural disorders 
reducing the possibility of excretion[32]. Second, if the 
tumor is formed by non-hepatocellular cells, as in the 
case of metastases, ICG could be retained by a group 
of hepatocytes surrounding the nodule and compressed 
by the nodule itself[33]. Third, if the nodule contains 
predominantly epithelial cells that are normally part of 
the biliary ducts (cholangiocarcinoma), they should not 
absorb the dye and should behave in a manner similar 
to metastases but with greater alterations in biliary 
delivery processes[34]. 
In clinical practice, however, these theoretical 
insights may not be taken into consideration because 
there is currently no clearly defined timing for i.v. 
injection. Indeed, especially at an early stage, increased 
vascularization of the neoplasm could result in greater 
exposure to the dye, regardless of the type of cells 
contained therein. The nodule behavior in the portal 
and tardive phases (with more or less washout) is 
also relevant in determining the amount of retained 
ICG. These factors translate into the absence of widely 
accepted guidelines for the intraoperative use of 
ICG-based fluorescence to differentiate benign from 
malignant nodules and among the different types of 
malignant tumors.
The key objective of ongoing studies (some of which 
are being performed in our medical institutions) is to 
enable differential diagnosis. ICG-based fluorescence 
may then be extremely helpful, as follows: (1) In 
the detection of small superficial malignant nodules 
not detected in the preoperative study (especially 
for managing metastases)[35]; and (2) in excluding 
the malignant nature of small superficial nodules of 
uncertain contrast medium behavior (especially useful 
for HCC in cirrhotic liver tissue)[36].
To date, however, some consolidated uses in liver 
surgery exist. First, it is common practice that me-
tastases in healthy livers are well visualized by the 
presence of an ICG capture ring due to the compression 
of the surrounding cells. This can be an advantage 
during laparoscopic surgery, where tactile sensation is 
not available as a guide for resection, and continuous 
monitoring with intraoperative ultrasound is both difficult 
Baiocchi GL et al . ICG fluorescence imaging in abdominal surgery
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These studies demonstrate that ICG is superior to both 
radioactive tracers and dyestuffs used to date[50,51]. In 
a recent multicentric Japanese series of 44 EGCs, the 
identification of sentinel node basins and the accuracy 
of metastatic node identification were both 100%[52]. 
The same strategy has been used for assessing 
colorectal tumors, investigating both the sentinel node 
basin and the enlarged mesocolic excision area draining 
the tumor site[53,54]. This latter principle is indeed the 
opposite of the sentinel node strategy: the goal would 
be to remove all lymph nodes that have received 
ICG as possible metastatic sites originating from the 
specific tumor site. The method is primarily useful for 
anatomical studies. Indeed, the ideal injection timing 
for the visualization of lymph nodes is not yet clear. 
Likely, after many hours, the dye may pass local lymph 
node drainage stations and move up to the central 
lymphatic pathways. The ideal study should therefore 
include (1) a preoperative tumor injection at different 
times before surgery up to an intraoperative injection; 
(2) the subsequent removal of individual lymph nodes; 
(3) a fluorescence evaluation for each node; and (4) a 
comparison of the final histological data. 
In clinical practice, the problems are mainly related 
to the feasibility of the injection. For cancer of the 
esophagus, stomach, and rectum, the injection can 
be endoscopic and intraoperative (despite causing an 
increase in time and costs), while in the proximal colon, 
it is easier to proceed with a serous injection during 
the initial stages of the intervention. Clinical experience 
shows that the injection should be limited to a few cc, 
as staining rapidly spreads in lymphatic and adipose 
tissues. If, during the injection, a few drops of dye come 
out of the serosa on the peritoneum, they stain the 
surrounding structures and the surgical instruments and 
cannot be washed away.
Despite the above limitations, the possible appli-
cations of this method for navigating lymph nodes 
appear to be of great interest and have very important 
clinical consequences. It is clearly emerging that the 
ideal lymphadenectomy needs to be individualized 
based on preoperative staging. However, in many cases, 
imaging is not able to discern with high probability, for 
example, between T1 and T2. On the one hand, limiting 
lymphadenectomy to stations of real potential interest 
could allow considerable time savings and reduce most 
of the major postoperative complications, often related 
to vascular lesions secondary to an excessive nodal 
dissection. On the other hand, for example, in rectal 
surgery, extending lymphadenectomy to stations, 
such as obturatory and inguinal nodes, that are not 
usually removed could reduce the rate of lymph node 
recurrence[55]. 
The same applies to periaortic stations in cardia and 
proximal stomach cancer, to the right colic artery basin 
in cecum and ascending colon cancer, and to flexural 
cancers. A small series of 10 hepatic and 10 splenic 
flexure colon cancers reported a 25% rate of changes 
to the mesocolon resection line due to ICG lymphatic 
flow visualization[56]. A subsequent series of 31 patients 
with splenic flexure cancer from the same study group 
confirmed that all metastatic nodes were included in 
the area determined by ICG lymphatic flow visualization 
and that interesting insights into the lymphatic spread 
of those tumors can be derived[57].
In the near future, it is important to search for 
a factor predicting the positivity of perigastric and 
extraperigastric nodes based on their ICG load. 
To date, a relationship between ICG quantities in 
dissected nodes and the likelihood of the nodes bearing 
metastases has not been demonstrated. Studies 
focusing on the sentinel node strategy have shown 
that the radioisotope count was a significant predictive 
factor for metastasis[58]. In contrast, some very limited 
series recently described patients with unexpected 
nodal metastases from colorectal cancer discovered by 
fluorescence visualization after i.v. ICG injection while 
searching for peritoneal carcinomatosis[59]; this report 
suggests that a particular trophism of intravenously 
injected ICG for cancer cells may be discovered.
Few studies have taken into account the same type 
of lymph node navigation in pancreatic cancers, which 
have extremely rich and complex lymph node spread 
patterns. A recent series of 10 patients undergoing 
laparoscopic pancreaticoduodenectomy for periampullary 
cancers with i.v. ICG injection during retroportal fat tissue 
dissection revealed a possible advantage in obtaining an 
R0 margin at this level[60]. However, at this stage, it is not 
possible to hypothesize and assess the clinical usefulness 
Figure 1  Colon perfusion before anastomosis during left colectomy. A few 
seconds after the i.v. injection of 0.3 mg/kg indocyanine green, bowel arteries 
clearly appear (A); thereafter, the bowel perfusion cut-off area becomes evident 
(B and C).
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of this strategy in pancreatic surgery[61]. Interestingly, 
a small series of pancreatic neuroendocrine tumors 
(NETs) has demonstrated a clear affinity of ICG for NET 
cells, which enables the removal of some residual tissue 
at the end of the first resection in laparoscopic distal 
pancreatectomy[62].
PeRITONeal CaRCINOmaTOsIs
This is an area where few studies have been 
conducted[63]. Peritoneal carcinomatosis remains a mode 
of metastatic diffusion that is largely devoid of real 
therapeutic strategies. Thus, finding it at an early stage 
while it is too small to be visible to the human eye, 
could represent a major clinical breakthrough. Some 
current studies are trying to link ICG to epithelial cell 
markers that should not be present on the peritoneum, 
which contains only mesothelial cells. No clinical 
outcomes of these studies are yet available, but some 
experimental settings have been developed in animal 
models. For instance, Cheng and colleagues have 
shown that a surgical navigation system combining 
optical molecular targets with an ICG-linked molecular 
probe is able to identify a peritoneal carcinomatosis 
site as small as 1.8 mm[64]. On the other hand, reports 
of some very limited series have shown that after 
i.v. injection, ICG is retained by cancerous cells in 
the peritoneum[65,66]. There is no clear explanation 
for these clinical observations, which, if confirmed in 
larger studies, may have very high clinical value as a 
comprehensive modality for staging visceral cancers. 
CONClUsION aND PeRsPeCTIVe
The key take-home messages from this overview 
are as follows. (1) The most well-established use of 
fluorescence imaging is for checking anastomotic 
stump perfusion in visceral surgery (Figure 1); Some 
prospective uncontrolled series and retrospective 
controlled studies, mainly dealing with colorectal and 
esophageal surgery, have confirmed the usefulness 
of this technique; (2) The second field of application 
for which there is a unanimous consensus in the 
literature pertains to visualization of the biliary anatomy 
during cholecystectomy (Figure 2). A comparison with 
intraoperative cholangiography demonstrated the 
superiority of fluorescence in terms of simplicity, timing, 
and efficacy; (3) In liver surgery, multiple possible 
uses of fluorescence have been described (tumor 
visualization, especially in laparoscopic surgery, vascular 
segmentation, biliary leak identification) (Figure 3). 
However, no comparative studies are available; (4) With 
regard to lymph node navigation in gastrointestinal 
tumors, most studies in the literature have focused 
on the sentinel node technique, whereas the use of 
fluorescence for complete lymphadenectomy has been 
described only by a few very experienced centers 
(Figure 4); and (5) Finally, there are some interesting 
A B
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Figure 2  Indocyanine green-enhanced biliary anatomy. During a difficult cholecystectomy for acute cholecystitis (A), the confluence between the cystic duct (CyD) 
and the common hepatic duct (CHD) is shown by fluorescence imaging (B); common hepatic duct (arrow) is further visualized before (C and D) and after (E and F) 
cystic duct division. ICG: Indocyanine green.
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Figure 3  Indocyanine green in liver surgery. Primary liver tumors show intense and complete staining because their hepatocytes take up ICG but do not secrete it 
(A and B); liver metastases show a ring appearance because their cells do not take up ICG but hepatocytes surrounding the nodule are compressed (C and D). ICG: 
Indocyanine green.
A B C
Figure 4  Indocyanine green fluorescence imaging in extended right hemicolectomy. The figure displays the right branches of middle colic vessel division during 
extended right hemicolectomy for transverse colon cancer. ICG injected in the tumor site spreads in nodes at the very proximal root of the artery. ICG fluorescence 
imaging allows a radical lymphadenectomy, including very small nodes (A and B). Only when all the stained nodes are removed may the nodal dissection be 
considered radical (C). ICG: Indocyanine green.
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preliminary findings regarding the use of fluorescence 
for the early detection of peritoneal carcinomatosis. 
An important issue pertains to the complexity and 
costs of this technology. The major positive feature is 
that the required training is minimal and the learning 
curve is extremely rapid, because the visualization is 
activated by either clicking a button on the camera or 
hitting a pedal. When considering the costs of ICG-
based fluorescence imaging, the relevant distinction is 
between the fixed costs of the equipment versus the 
variable costs of the injections. The highest costs lie 
in obtaining a NIR fluorescence camera system with 
dedicated optical devices, cameras, and light cables. 
Depending on the system chosen (goggles, handheld, 
or stand alone), the cost of the system varies from 
several thousands to hundreds of thousands of USD (and 
similarly in other currencies). Nowadays, many major 
companies sell these tools; therefore, at the fast pace 
at which cost-saving technological change and updating 
are occurring, it is very likely that in the next 5 to 10 
years most operating theaters will be equipped with 
the technology required to display the ICG-generated 
fluorescence. Once the NIR fluorescence camera system 
is available in a hospital, the additional cost of each 
surgical procedure utilizing ICG-based fluorescence 
imaging is relatively limited: as a matter of example, in 
Italy, Japan, and the United States, a 25 mg vial of ICG 
costs 80 euros, 588 yen, and 65 USD, respectively[41]. 
The imaging of fluorescence emitted by ICG is a 
simple, fast, and relatively inexpensive tool without 
side effects that has numerous different applications in 
surgery not only for treating cancers affecting the visceral 
and hepatobiliary systems but also for visualizing the 
biliary tree during difficult cholecystectomies. The fast 
pace at which technological development is occurring 
in this area and the ever-increasing availability of more 
powerful visual systems that can utilize this tool will 
transform some of these applications into the standard of 
care in the near future. 
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